Healthcare Sector Review: McKesson Loses to Cardinal Health, Corcept Prospects High

Leerink upgraded Corcept Therapeutics Inc. (NASDAQ:CORT) citing increased confidence in Korlym’s approval prospects ahead of the February 17 PDUFA date.

The shares closed at $3.40, up $0.28, or 8.97%, on the day. Its market capitalization is $286.39 million.

Cleveland Research said checks indicate McKesson Corporation (NYSE:MCK) lost the Safeway (NYSE:SWY) contract to Cardinal Health (NYSE:CAH), which was upgraded by the firm to Buy.

The shares closed at $75.97, down $1.48, or 1.91%, on the day. Its market capitalization is $18.66 billion.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.